A truncated fragment of Ov-ASP-1 consisting of the core pathogenesis-related-1 (PR-1) domain maintains adjuvanticity as the full-length protein
Jingjing Guo(Johns Hopkins University), Yusen Zhou(Southeast University), Wenjun Xiao(Sun Yat-sen University), Lanying Du(Georgia State University), Shibo Jiang(Shanghai Medical College of Fudan University), Hong Yu(University of Massachusetts Lowell), Yi Yang(First Hospital of Lanzhou University), Sara Lustigman(New York Blood Center), Zhihua Kou(Institute of Microbiology), Weilai Sun(Institute of Microbiology)
Cited by 12
Related Papers
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
|Cell Research|2020|1.4k
Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
|Cellular and Molecular Immunology|2020|759
Draft Genome of the Filarial Nematode Parasite <i>Brugia malayi</i>
|Science|2007|624
Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses
|Frontiers in Microbiology|2020|442
Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor
|Nature Communications|2014|400